How Ketamine Tablets Affect Blood Pressure and Heart Rate

Ketamine tablets can cause a temporary rise in blood pressure and heart rate, typically peaking within 30 to 60 minutes of dosing and returning to baseline within a few hours. This is a known sympathomimetic effect of ketamine itself, not a sign that something has gone wrong, but it's the reason a prescriber-managed oral ketamine protocol includes baseline vital sign checks and follow-up monitoring. The size of the effect depends on dose, individual cardiovascular health, and route of administration, with oral and sublingual tablets generally producing milder cardiovascular changes than intravenous (IV) ketamine because of how the tablet form is absorbed and metabolized.

This is educational information, not medical advice. If you're prescribed oral ketamine tablets or considering treatment, talk with your prescriber about your personal cardiovascular history before starting.

Why Ketamine Raises Blood Pressure and Heart Rate

Ketamine and its active metabolite norketamine stimulate the sympathetic nervous system, the branch of the autonomic nervous system responsible for the body's "fight or flight" response. Researchers believe this happens in part through inhibition of norepinephrine and dopamine reuptake and through direct effects on central autonomic control centers, distinct from ketamine's action on the NMDA (N-methyl-D-aspartate) receptor, the glutamate receptor thought to underlie its antidepressant effects. That sympathetic stimulation is what produces the transient increases in heart rate and blood pressure that show up across ketamine's various delivery routes.

The size of the cardiovascular response tracks closely with how quickly and how high plasma ketamine levels rise. You can read more about how dose and absorption interact in our guide to ketamine bioavailability explained why sublingual administration matters and in our breakdown of peak plasma levels. Oral tablets that are swallowed pass through the liver before reaching general circulation, a process called first-pass metabolism, which converts a large share of the dose into norketamine and blunts the peak concentration compared with IV administration. Sublingual or buccal tablet use, where the tablet dissolves under the tongue or against the cheek, bypasses some of that first-pass effect and can produce somewhat higher peaks, though still generally lower than IV infusion. For more on timing, see our guide to onset and duration.

What the Research Says

According to peer-reviewed reviews of ketamine's side-effect profile indexed on PubMed, transient elevations in blood pressure and heart rate are among the most consistently reported physiological effects of ketamine dosing across routes, alongside dissociation and mild nausea. Most of the published cardiovascular data comes from IV ketamine trials for treatment-resistant depression, since oral and sublingual dosing has a smaller research base; this is one of several areas where evidence on the oral route remains less complete than for IV or intranasal ketamine, a limit worth keeping in mind when interpreting any specific number.

The FDA-approved labeling for esketamine (Spravato), a nasal spray form of ketamine and the only ketamine-based medication with FDA approval for treatment-resistant depression, requires clinicians to check blood pressure before dosing and again at roughly 40 minutes post-dose, with guidance on what to do if readings are significantly elevated. Oral ketamine tablets for depression are prescribed off-label and are compounded rather than FDA-approved, so there's no single federally mandated monitoring protocol, but many prescribers apply similar baseline-and-follow-up vital sign checks as a matter of clinical practice. You can read more about the current evidence base in our guide to oral ketamine safety and efficacy the evidence.

Who Is at Higher Risk

People with uncontrolled hypertension, significant coronary artery disease, arrhythmia, aneurysm, or a recent cardiac event are generally screened out of ketamine treatment protocols because the sympathomimetic effect can add meaningful strain in those situations. A responsible prescriber will ask about your cardiovascular history, current blood pressure medications, and any prior reactions to stimulants before writing a prescription, and will check baseline vitals before your first dose. Combining ketamine with other substances that raise heart rate or blood pressure, including stimulants, decongestants, and some over-the-counter supplements, can compound the effect, so it's worth reviewing your full medication and supplement list with your prescriber. Our guide to monitoring your response to ketamine tablet treatment covers what an ongoing check-in schedule typically looks like.

Tablets Versus Other Routes

Oral ketamine tablets generally produce a more gradual rise in blood pressure and heart rate than IV infusion because swallowed tablets reach lower peak plasma concentrations, spread out over a longer absorption window. Sublingual tablets sit between the two: they skip some first-pass metabolism, which can produce a somewhat quicker and higher peak than swallowed tablets, though still typically less abrupt than an IV push. If you're comparing tablets with other formats, our guide to tablets versus intramuscular ketamine covers how absorption speed differs by route, and our explainer on how long does ketamine tablet stay in your system covers the broader pharmacokinetic picture. Whichever route you use, the cardiovascular response is a reason legitimate ketamine treatment happens under medical supervision rather than through unmonitored self-dosing.